About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
BOARD MEETINGS
Board
Meetings
Apollo Hospitals Enterprise Ltd.
From Date
:
To Date
:
Source Date
Board Meeting Date
Details
15-Oct-2024
06-Nov-2024
Quarterly Results
31-Jul-2024
03-Aug-2024
ESOP
31-Jul-2024
13-Aug-2024
Quarterly Results
03-May-2024
30-May-2024
Quarterly Results & Final Dividend
17-Jan-2024
08-Feb-2024
Interim Dividend & Quarterly Results
30-Oct-2023
09-Nov-2023
Quarterly Results
18-Jul-2023
11-Aug-2023
Quarterly Results
11-May-2023
30-May-2023
Audited Results & Quarterly Results & Final Dividend
31-Jan-2023
14-Feb-2023
Quarterly Results & Interim Dividend
28-Nov-2022
30-Nov-2022
Inter-alia, to consider and approve the issuance of unsecured Non-Convertible Debentures on private placement basis, within the limits approved by the Board of Directors and shareholders at their meeting held on 25th May 2022 and 25th August 2022 respective
14-Oct-2022
10-Nov-2022
Quarterly Results
26-Jul-2022
11-Aug-2022
Quarterly Results
26-Apr-2022
25-May-2022
Dividend & Audited Results
24-Jan-2022
11-Feb-2022
Quarterly Results
25-Oct-2021
12-Nov-2021
Quarterly Results
04-Aug-2021
13-Aug-2021
Quarterly Results
08-Jun-2021
23-Jun-2021
Quarterly Results & Dividend & Audited Results
28-Jan-2021
12-Feb-2021
Quarterly Results
18-Jan-2021
22-Jan-2021
Preferential Issue of shares(Cancelled)
03-Nov-2020
11-Nov-2020
Quarterly Results
Page
1
of
5
Prev
||
Next
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.